Predictors and moderators of symptom change during cognitive-behavioral therapy or supportive psychotherapy for body dysmorphic disorder

2021 ◽  
Vol 287 ◽  
pp. 34-40
Author(s):  
Katharine A. Phillips ◽  
Jennifer L. Greenberg ◽  
Susanne S. Hoeppner ◽  
Hilary Weingarden ◽  
Sheila O'Keefe ◽  
...  
2019 ◽  
Vol 76 (4) ◽  
pp. 363 ◽  
Author(s):  
Sabine Wilhelm ◽  
Katharine A. Phillips ◽  
Jennifer L. Greenberg ◽  
Sheila M. O’Keefe ◽  
Susanne S. Hoeppner ◽  
...  

2021 ◽  
Vol 80 ◽  
pp. 102386
Author(s):  
J. Gayle Beck ◽  
Joshua D. Clapp ◽  
William Unger ◽  
Melissa Wattenberg ◽  
Denise M. Sloan

2020 ◽  
Vol 44 (3) ◽  
pp. 596-610
Author(s):  
Angela Fang ◽  
Gail Steketee ◽  
Aparna Keshaviah ◽  
Elizabeth Didie ◽  
Katharine A. Phillips ◽  
...  

2011 ◽  
Vol 4 (4) ◽  
pp. 381-396 ◽  
Author(s):  
Hilary Weingarden ◽  
Luana Marques ◽  
Angela Fang ◽  
Nicole LeBlanc ◽  
Ulrike Buhlmann ◽  
...  

2010 ◽  
Vol 17 (3) ◽  
pp. 248-258 ◽  
Author(s):  
Jennifer L. Greenberg ◽  
Sarah Markowitz ◽  
Michael R. Petronko ◽  
Caitlin E. Taylor ◽  
Sabine Wilhelm ◽  
...  

Author(s):  
Katharine A. Phillips ◽  
Rachel A. Simmons

This chapter illustrates how the authors treated a representative patient with body dysmorphic disorder (BDD) using both medication and cognitive-behavioral therapy (CBT). The case example illustrates engagement strategies, treatment selection, implementation of recommended treatment strategies, approaches to some commonly encountered decision points, and possible solutions to frequently encountered treatment challenges. Following the case example, the authors comment on these issues. The chapter discusses approaches to patients who desire cosmetic treatment rather than mental health treatment. Factors involved in the decision to use CBT, pharmacotherapy, or both treatment modalities for BDD are also covered.


Sign in / Sign up

Export Citation Format

Share Document